Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug 21;325(5943):1001-5.
doi: 10.1126/science.1176676. Epub 2009 Jul 23.

Bcl6 mediates the development of T follicular helper cells

Affiliations

Bcl6 mediates the development of T follicular helper cells

Roza I Nurieva et al. Science. .

Abstract

A fundamental function of CD4+ helper T (T(H)) cells is the regulation of B cell-mediated humoral immunity. Development of T follicular helper (T(FH)) cells that provide help to B cells is mediated by the cytokines interleukin-6 and interleukin-21 but is independent of TH1, TH2, and TH17 effector cell lineages. Here, we characterize the function of Bcl6, a transcription factor selectively expressed in T(FH) cells. Bcl6 expression is regulated by interleukin-6 and interleukin-21. Bcl6 overexpression induced T(FH)-related gene expression and inhibited other T(H) lineage cell differentiation in a DNA binding-dependent manner. Moreover, Bcl6 deficiency in T cells resulted in impaired T(FH) cell development and germinal center reactions, and altered production of other effector T cell subsets. Our data thus illustrate that Bcl6 is required for programming of T(FH) cell generation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Bcl6 regulates TFH-specific gene expression. (A) Naïve T cells were activated with antibodies to CD3 and CD28, and with or without indicated cytokines for 1 or 2 days. Bcl6 mRNA expression was analyzed by real-time RT-PCR. The graph shows means ± SD. *P < 0.005; **P < 0.001 when comparing IL-6 and IL-6 plus TGFβ to nontreated sample, analysis of variance (ANOVA) test. ++P < 0.001 when comparing IL-21 and IL-21 plus TGFβ to nontreated sample, ANOVA test. (B) Naïve OT-II T cells were activated with antibodies to CD3 and CD28 alone or together with IL-6 or IL-21 and with antibodies to IL-4, IFNγ, and TGFβ, and infected with a bicistronic retrovirus containing internal ribosomal entry site green fluorescent protein (GFP) expressing Bcl6 or a vector control virus. mRNA expression of indicated genes was assessed by real-time RT-PCR. (C) Naïve OT-II T cells were activated with antibodies to CD3 and CD28 alone and infected with retroviruses expressing Bcl6, Bcl6 mutants (ZF3 and ZF5), or vector alone. GFP+ cells were sorted from (B) and (C) and restimulated for 4 hours with antibody to CD3. mRNA expression of indicated genes was analyzed by real-time RT-PCR. The data shown were normalized to the expression of a reference gene, Actb. The graph shows means ± SD. *P < 0.005; **P < 0.001, t test. The data represent at least three independent experiments with consistent results.
Fig. 2
Fig. 2
Bcl6 suppresses TH17 and TH1 differentiation. (A and B) Naïve OT-II T cells were activated under TH17 conditions and infected with retroviruses expressing Bcl6, Bcl6 mutants, or vector alone. GFP+ cells sorted by fluorescence-activated cell sorting (FACS) were restimulated with antibody to CD3, and mRNA expression of indicated genes was analyzed by real-time RT-PCR (A). The data shown were normalized to the expression of reference gene Actb. The graph shows means ± SD. *P < 0.005; **P < 0.001 when comparing Bcl6 and ZF3 to vector alone, ANOVA test. ++P < 0.001 when comparing Bcl6 and ZF5 to vector alone, ANOVA test. IL-17–expressing cells were measured by intracellular staining of the sorted GFP+ population (B). Numbers in dot-plot quadrants represent the percentages. (C) EL-4 cells were transfected with a vector containing the firefly luciferase gene under the control of the IL-17 promoter and the CNS2 region, a vector expressing Renilla luciferase, and vectors expressing RORγt, Bcl6 wild-type, various Bcl6 mutants, or vector alone. The firefly luciferase activity was determined and normalized to Renilla luciferase. Values were also normalized to vector alone. The graph shows means ± SD. (D and E) Naïve OT-II T cells were activated under TH1 conditions and infected with the indicated viruses. GFP+ cells were restimulated with antibody to CD3, and mRNA expression of the indicated genes was analyzed by real-time RT-PCR (D). The data shown were normalized to the expression of reference gene Actb. The graph shows means ± SD. *P < 0.005; **P < 0.001, t test. IFNγ expression was analyzed by intracellular staining on FACS-sorted GFP+ cells (E). Numbers in dot-plot quadrants represent the percentages. The data represent at least three independent experiments with consistent results.
Fig. 3
Fig. 3
Bcl6 deficiency causes defective T cell differentiation in vitro. Naïve CD4+ T cells from Bcl6−/− mice and their littermate control mice carrying the OT-II TcR transgene were activated under TFH (A), TH0 and TH1 (B), TH17 (C), and Treg (TGFβ or TGFβ with antibodies to IL-4 and IFNγ) (D) conditions. Five days later, cells were assessed for IFNγ and IL-17 production [(A) to (C)] or Foxp3 expression (D) using intracellular staining. Numbers in FACS plot quadrants represent the percentages. mRNA expression of various genes was analyzed by real-time RT-PCR, and the data shown were normalized to the expression of reference gene β-actin. The graph shows means ± SD. P values were calculated using a t test comparing wild-type and Bcl6−/− CD4+ T cells and are indicated as follows: *P < 0.005; **P < 0.001. The experiments were repeated three times with consistent results.
Fig. 4
Fig. 4
Bcl6 is necessary for the generation of TFH cells in vivo. (A and B) Naïve CD4+ cells from wild-type (WT) or Bcl6−/− mice were mixed with WT B cells and transferred into Rag1−/− mice (3 mice per group). The recipient mice were immunized subcutaneously with KLH emulsified in Freund’s complete adjuvant (FCA). In (B), recipient mice were also treated with antibody to IL-4. Seven days after the immunization, germinal center B cells were determined by staining with GL-7, FAS and B220 antibodies, and TFH cells by CD4 and CXCR5 antibodies. Numbers in dot-plot quadrants represent the percentages in gated T and B cells, respectively. Spleen cells from immunized mice were stimulated with the indicated concentration of KLH. Effector cytokines were measured after 4 days of treatment. The graph shows means ± SD. P values were calculated using a t test comparing CXCR5 expression on T cells or GL7/Fas expression on B cells between mice transferred with WT or Bcl6-deficient T and B cells, respectively, and are indicated as follows: *P < 0.005; **P < 0.001. The results are representative of multiple mice (n = 6 per group) from two independent experiments with similar results. (C) Mixed–bone marrow chimeric mice (n = 15) were generated and immunized with KLH in FCA. Spleen cells were stained with antibody to CD45.2 to distinguish WT and Bcl6 knockout compartments and then analyzed for the germinal center B cells and TFH cells. P values were calculated using a t test comparing CXCR5 and GL7/Fas expression between WT and Bcl6-deficient T and B cells, respectively, and are indicated as follows: *P < 0.005; **P < 0.001. The results are a representative of multiple mice (n = 15) from three independent experiments with similar results.

Comment in

Similar articles

Cited by

References

    1. Vinuesa CG, Tangye SG, Moser B, Mackay CR. Nat. Rev. Immunol. 2005;5:853. - PubMed
    1. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Immunity. 2009;30:324. - PMC - PubMed
    1. King C, Tangye SG, Mackay CR. Annu. Rev. Immunol. 2008;26:741. - PubMed
    1. Nurieva RI, et al. Immunity. 2008;29:138. - PMC - PubMed
    1. Vogelzang A, et al. Immunity. 2008;29:127. - PubMed

Publication types

MeSH terms